Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting
Crossref DOI link: https://doi.org/10.1186/s12959-016-0082-4
Published Online: 2016-04-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosencher, Nadia
Samama, Charles M.
Feuring, Martin
Brueckmann, Martina
Kleine, Eva
Clemens, Andreas
Frostick, Simon
Funding for this research was provided by:
Boehringer Ingelheim (DE)